Atrial amyloidosis and atrial fibrillation: A gender-dependent "arrhythmogenic substrate"?

European Heart Journal

Volumn 25, Issue 14, 2004, Pages 1185-1186

  Goette, Andreas ^a   Röcken, Christoph ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR; GUANYLATE CYCLASE; PREALBUMIN;

AGE DISTRIBUTION; ARRHYTHMOGENESIS; ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; ENZYME ACTIVATION; FIBROSING ALVEOLITIS; HEART AMYLOIDOSIS; HEART ATRIUM APPENDAGE; HEART ATRIUM CONDUCTION; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MITRAL VALVE DISEASE; P WAVE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SEX DIFFERENCE; SINUS RHYTHM;

AMYLOID; AMYLOIDOSIS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; ATRIAL NATRIURETIC FACTOR; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; HEART ATRIA; HEART VALVE DISEASES; HUMANS;

EID: 3042795033     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.04.014     Document Type: Article

References (11)

1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 415:2002;219-226
2. Goette A., Staack T., Röcken C., et al. Increased expression of extracellular-signal regulated kinases and angiotensin-converting enzyme in human atria during atrial fibrillation. J. Am. Coll. Cardiol. 35:2000;1669-1677
3. Davies M.J., Pomerance A. Pathology of atrial fibrillation in man. Br. Heart J. 34:1972;520-525
4. Röcken C., Peters B., Juenemann G., et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation. 106:2002;2091-2097
5. Röcken C., Sletten K. Amyloid in surgical pathology. Virchows Archiv. 443:2003;3-16
6. Leone O., Boriani G., Chiappini B., et al. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J. 25:2004;1237-1241
7. Steiner I. The prevalence of isolated atrial amyloid. J. Pathol. 153:1987;395-398
8. Babiker F.A., De Windt L.J., van Eickels M., et al. 17β-Estradiol antagonizes cardiomycyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Circulation. 109:2004;269-276
9. Jankowski M., Rachelska G., Donghao W., et al. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc. Natl. Acad. Sci. USA. 98:2001;11765-11770
10. Tabata T., Oki T., Yamada H., et al. Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide. Eur. J. Echocardiogr. 1:2000;130-137
11. Yoshihara F., Nishikimi T., Sasako Y., et al. Plasma atrial natriuretic peptide concentration inversely correlates with left atrial collagen volume fraction in patients with atrial fibrillation: plasma ANP as a possible biochemical marker to predict the outcome of the maze procedure. J. Am. Coll. Cardiol. 39:2002;288-294